IT8621192A0 - Composizione farmaceutica. - Google Patents

Composizione farmaceutica.

Info

Publication number
IT8621192A0
IT8621192A0 IT8621192A IT2119286A IT8621192A0 IT 8621192 A0 IT8621192 A0 IT 8621192A0 IT 8621192 A IT8621192 A IT 8621192A IT 2119286 A IT2119286 A IT 2119286A IT 8621192 A0 IT8621192 A0 IT 8621192A0
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IT8621192A
Other languages
English (en)
Other versions
IT1213453B (it
Inventor
Gerhard Sauer
Eberhard Amtmann
Klaus W Hummel
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of IT8621192A0 publication Critical patent/IT8621192A0/it
Application granted granted Critical
Publication of IT1213453B publication Critical patent/IT1213453B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT8621192A 1985-08-02 1986-07-21 Composizione farmaceutica. IT1213453B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3527871 1985-08-02
DE3620939 1986-06-23

Publications (2)

Publication Number Publication Date
IT8621192A0 true IT8621192A0 (it) 1986-07-21
IT1213453B IT1213453B (it) 1989-12-20

Family

ID=25834701

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8621192A IT1213453B (it) 1985-08-02 1986-07-21 Composizione farmaceutica.

Country Status (14)

Country Link
US (1) US4851435A (it)
JP (1) JPH0618786B2 (it)
AU (1) AU585380B2 (it)
BE (1) BE905195A (it)
CA (1) CA1295944C (it)
CH (1) CH673224A5 (it)
DK (1) DK369186A (it)
FR (1) FR2591483B1 (it)
GB (1) GB2178957B (it)
GR (1) GR862030B (it)
IT (1) IT1213453B (it)
LU (1) LU86533A1 (it)
NL (1) NL8601895A (it)
SE (1) SE501592C2 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392906B (de) * 1987-10-08 1991-07-10 Hoffmann La Roche Pharmazeutische praeparate zur oralen verabreichung
CA2010511A1 (en) * 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
WO1996014841A1 (en) * 1994-11-14 1996-05-23 Ct-Holding S.A. Antiviral and antitumor pharmaceutical compositions
DE10117728A1 (de) * 2001-04-09 2002-10-17 Biosphings Ag Pharmazeutische Formulierungen für Xanthogenate
DE10156617A1 (de) * 2001-11-17 2003-05-28 Biosphings Ag Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
EP2422789B1 (en) * 2004-05-19 2017-11-22 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Injectable coposition comprising sodium deoxycholate
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
DE102006014390A1 (de) * 2006-03-29 2007-10-04 Biosphings Ag Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung
CN101796024A (zh) * 2007-07-03 2010-08-04 露马维塔股份公司 三环癸-9-基-黄原酸酯的立体异构体
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020183A (en) * 1974-12-03 1977-04-26 Ortho Pharmaceutical Corporation Nonionic surface active anti-herpes simplex viral agents
KR870001238B1 (ko) * 1980-11-26 1987-06-26 메르츠+캄패니 게엠베하 앤드 캄패니 크산틴산염의 제조방법
CA1174978A (en) * 1980-11-26 1984-09-25 Arthur Scherm Xanthates
DK315482A (da) * 1981-07-20 1983-01-21 Kimberly Clark Co Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden

Also Published As

Publication number Publication date
GB8618820D0 (en) 1986-09-10
BE905195A (fr) 1987-01-29
SE8603284D0 (sv) 1986-08-01
GR862030B (en) 1986-12-24
JPH0618786B2 (ja) 1994-03-16
SE501592C2 (sv) 1995-03-20
FR2591483A1 (fr) 1987-06-19
JPS6259223A (ja) 1987-03-14
AU6064886A (en) 1987-02-05
GB2178957B (en) 1989-12-28
DK369186D0 (da) 1986-08-01
CA1295944C (en) 1992-02-18
CH673224A5 (it) 1990-02-28
DK369186A (da) 1987-02-03
NL8601895A (nl) 1987-03-02
FR2591483B1 (fr) 1990-08-10
AU585380B2 (en) 1989-06-15
IT1213453B (it) 1989-12-20
US4851435A (en) 1989-07-25
SE8603284L (sv) 1987-02-03
LU86533A1 (fr) 1988-02-02
GB2178957A (en) 1987-02-25

Similar Documents

Publication Publication Date Title
DE3685409D1 (de) Antitumorzusammensetzung.
FI865037A0 (fi) Mikrobicida kompositioner.
FI862094A (fi) Bornerande terapeutisk komposition.
ES2019061B3 (es) Composicion quimiluminiscente.
DE3681140D1 (de) Polyaethylenzusammensetzung.
DE3668414D1 (de) Antidiarrhoee-zusammensetzungen.
DE3684564D1 (de) Veterinaere zusammensetzungen.
FI854573A (fi) Farmaceutiska kapslar med foerdroejd frigoering.
DE3684626D1 (de) Schmerzstillende zusammensetzung.
DE3684003D1 (de) Propylen-polymer-zusammensetzung.
FI893643A0 (fi) Farmaceutiska kompositioner.
FI872733A0 (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3583866D1 (de) Kompositmasse.
DE3669105D1 (de) Therapeutische zusammensetzung.
FI872313A (fi) Farmaceutiska kompositioner.
DE3686740D1 (de) Einkomponenthaertbare zusammensetzung.
IT1213453B (it) Composizione farmaceutica.
FI883673A (fi) Farmaceutiska kompositioner.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT1209615B (it) Composizione farmaceutica
NO862439L (no) Farmasoeytiske preparater.
FI874414A (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
FI852658L (fi) Farmaceutiska aemnen.
FI860449A0 (fi) Komposition foer behandling av graesmatta.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960731